RT Journal Article
SR Electronic
T1 Risk factors, diagnosis and management of venous thromboembolic disease in pregnancy
JF Breathe
JO Breathe
FD European Respiratory Society
SP 220018
DO 10.1183/20734735.0018-2022
VO 18
IS 2
A1 Edebiri, Osasere
A1 Ní Áinle, Fionnuala
YR 2022
UL http://breathe.ersjournals.com/content/18/2/220018.abstract
AB Venous thromboembolism (VTE) in pregnancy is a leading cause of maternal morbidity and mortality. However, despite the significant associated clinical burden and potentially devastating societal impact, there is still a paucity of data surrounding its prevention and management. Consequently, international guideline recommendations vary widely. Exclusion of pregnant women from clinical trials in the past has contributed to knowledge gaps. However, recently published and ongoing studies demonstrate that excellent clinical trials in pregnancy are achievable. This review will discuss prevention, diagnosis and treatment of VTE in pregnancy, and will also explore priorities for future research.Educational aimsTo gain an understanding of current knowledge on risk factors for pregnancy-associated venous thromboembolism (PA-VTE).To gain an understanding of the diagnosis of PA-VTE.To review up-to-date approaches to preventing and treating PA-VTE.To discuss possible limitations in current research and areas which require improvement.Venous thromboembolism in pregnancy is a leading cause of maternal morbidity and mortality. However, individualised clinical risk assessment and recent advances in clinical prediction rules for pulmonary embolism have the potential to improve management. https://bit.ly/3mjtHg2